TickerGuard
Buy Day today: Good (67) Broad market participation · no major macro event

Viatris Inc (VTRS)

Healthcare Drug Manufacturers - Specialty & Generic
17.60 $
+0.4% vs. previous close
Closing price · As of: 3. Aug 2026

Viatris Inc (VTRS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Revenue" came in at 14,300 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Income Statement VTRS
Tick rows to compare them in a chart (up to 4) 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
7,720 9,429 11,077 11,908 11,434 11,501 11,946 17,886 16,263 15,427 14,739 14,300
4,192 5,213 6,380 7,125 7,432 7,603 8,149 12,311 9,766 8,988 9,116 9,286
3,528 4,216 4,697 4,783 4,002 3,898 3,797 5,576 6,497 6,439 5,624 5,014
582 672 827 783 705 640 513 681 662 805 809 966
1,626 2,181 2,496 2,576 2,441 2,564 3,344 4,529 4,179 4,310 4,426 3,794
2,175 2,755 3,998 3,346 3,096 3,182 4,008 5,610 4,882 5,672 5,614 7,677
1,353 1,461 699 1,437 906 716 -211 -34 1,615 766 10 -2,663
333 336 455 535 542 517 498 636 592 573 550 471
975 915 122 903 298 154 -721 -664 2,813 203 -623 -3,665
41 68 -358 207 -54 138 -51 605 735 148 11 -150
929 848 480 696 353 17 -670 -1,269 2,079 55 -634 -3,515
1,874 2,287 2,100 3,243 2,951 2,691 1,993 4,478 6,433 3,517 2,820 -395

Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?